the abeona therapeutics company is a disease leading gene therapy company. it is a disease leading gene therapy company, and its clinical development is a major concern. the adeno - associated virus gene therapy program is the only program in the world that has a gene therapy muscles and the other therapy in development and in clinical trials. we have reported on positive clinical data in our lead program for lysosomal storage diseases as well as our programs for epidermolysis bullosa. we have achieved multiple regulatory designations in multiple programs. we are further developing our work in the library of next generation av viral vectors with our our our aim viral vector platforms.